Jupiter Endovascular
Nicole Barber is an accomplished regulatory affairs executive with extensive experience in the medical device and biotechnology industries. Currently serving as the Senior Director of Regulatory Affairs and Compliance Officer at Jupiter Endovascular since January 2025, Nicole previously held positions including Vice President of Regulatory & Clinical Affairs at Valencia Technologies and Vice President of Regulatory Affairs and Compliance Officer at CeloNova BioSciences, Inc. Notable expertise includes managing regulatory processes for class III medical devices, including active implantable neuromodulators and coronary stents, as well as overseeing compliance for complex biologics and combination products. Nicole's educational background includes a Bachelor’s degree in Biochemistry from California Polytechnic State University-San Luis Obispo and a Master’s degree in Jurisprudence with a concentration in Pharmaceutical & Medical Device Law & Compliance from Seton Hall University School of Law.
This person is not in any teams
This person is not in any offices
Jupiter Endovascular
Imagine a world where you could bring the precision and control of surgery to catheter-based therapies. For decades, endovascular procedures have been constrained by the technological limitations of catheters that lose stability and control within the anatomy. We have created a new class of therapies to overcome these constraints by using Endoportal Control to mimic the precision and control of direct surgical access, while maintaining the minimally invasive profile of an endovascular intervention. Our vision is big, spanning the breadth of cardiovascular disease where we see compelling opportunities to reimagine therapies for millions of patients. Jupiter Endovascular is a medical technology startup located in the San Francisco Bay Area, led by a team of successful medical device entrepreneurs. We have big ambitions, with a culture built on innovation, teamwork, and speed. We have raised capital from a diversified investor base, including venture capital, private equity, corporate strategic investors, and clinician angel investors.